COL18A1 and metastatic malignant neoplasm: High serum endostatin levels have been described in metastatic cancer patients and most published studies show that high levels of the protein are correlated with aggressive disease or poor prognosis, which is in agreement with our results (Feldman et al, 2002; Bono et al, 2003).